Retatrutide has emerged as a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By https://rapheceutique.com/index.php/pain-and-comfort/